Virginia Tech wins $27 million contract for infectious disease research

BLACKSBURG, Va. — Virginia Tech will use $27 million to support infectious disease research around the world.

The Virginia Bioinformatics Institute and the CyberInfrastructure Group will use the funding from the National Institute of Allergy and Infectious Diseases to integrate information on pathogens, provide key resources and tools to scientists, and help researchers to analyze genomic, proteomic and other data arising from infectious disease research.

“The new award from the NIH will allow us to continue our work to support infectious disease research and the development of vaccine, diagnostic or therapeutic targets for countermeasures,” said Bruno Sobral, professor and director of the CyberInfrastructure Group and principal investigator of the project.

“As we move ahead, we will be working hand-in-hand with a wide range of partners, including medical schools and public health institutions interested in translating the very latest scientific discoveries and innovation into practical health benefits for society at large.”